Search Results 1501-1510 of 20899 for Informed consent

1. Low-grade UTUC Treated with Nadofaragene Firadenovec Administered to Renal Pelvis - Mayo Clinic

   Aged ≥18 years at the time of signing informed consent. 2. Able to give written informed consent. 3. Have biopsy-proven low-grade upper tract urothelial ...

2. A Study Evaluating the Effectiveness of Oral Vismodegib in Various Histologic Subtypes of High Risk or Locally Advanced Basal Cell Carcinoma - Mayo Clinic

   A signed and data informed consent; Willing to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures; 18 years of age or ...

3. Study To Evaluate The Efficacy And Safety Of Ersodetug In Patients With Inadequately Controlled Hypoglycemia Due To Tumor-Associated Hyperinsulinism - Mayo Clinic

   Male or female participants of ≥18 years of age who provide written informed consent. Participants with a clinical diagnosis and laboratory confirmation of ...

4. Treatment of Moderate to Severe Refractory Crohn's Disease - Mayo Clinic

   Subjects must be able to understand and sign informed consent and be willing and able to complete all specified procedures and visits. Exclusion Criteria: 1 ...

5. Lymphocytes in Psychiatric Disorders - Mayo Clinic

   Inability or unwillingness of individual to give written informed consent. Fever, chills, or other objective evidence of ongoing infection at a time of the ...

6. Riluzole In Spinal Cord Injury Study - Clinical Trials

   Signed Informed Consent Document (ICD) by patient, legal representative or witness; Able to receive the Investigational Drug within 12 hours of injury ...

7. Evaluate the Safety and Efficacy of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial Surgery (ENCASE II) - Mayo Clinic

   from the time of signing the informed consent form through 90 days post-surgery. intra-operative 1. Subjects with surgical wound classification Class I ...

8. A Study Of MCG In Cardiac Amyloidosis - Mayo Clinic

   Age ≥ 18 years on the date of consent. Ability for participant to comply with study requirements. Written informed consent. Exclusion Criteria: Pregnant or ...

9. Correlative Biomarker Study in Patients With Myeloproliferative Disorders - Mayo Clinic

   Patients must have signed an informed consent to participate in a Myeloproliferative Disorders Research Consortium (MPD-RC) treatment study to which this ...

10. Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP) (VAYHIT1) - Mayo Clinic

    - Signed informed consent prior to participation in the study. - Male or female participants aged 18 years and older on the day of signing informed consent - ...